Shandong Lukang Pharmaceutical Co.,Ltd.’s Net Profit Rose 2.9% in First Quarter of 2023

Shandong Lukang Pharmaceutical Co.,Ltd. (山东鲁抗医药股份有限公司) (600789.SH) reported a net profit of 47.4 million yuan in the first quarter of 2023, up 2.9% year-on-year.

Meanwhile, the company posted 1.7 billion yuan in revenue, up 25.4% year-on-year.

At the end of the reporting period, it had 8.5 billion yuan in total assets and 5 billion yuan in total liabilities, with a liability-to-asset ratio of 58.3%.